Work

Advances in Psoriasis Treatment: Combining Secukinumab With Phototherapy

Year: 2024

Type: article

Abstract: This article explores the benefits of combining secukinumab, a biologic IL-17 inhibitor, with narrowband UVB phototherapy in treating moderate to severe psoriasis. It presents findings from five patients who demonstrated significant skin clearance and improved quality of life through this combination approach, suggesting that it can be an effective treatment for resistant forms of the disease

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.13952564

Author: Rajabov Temurbek

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6911646517

FWCI:

Cites:

Cited by:

Related to: